http://www.cookmedical.com/newsroom.doCook Medical News Releasesen_USCopyright Cook Medical 2009webmaster@cook-inc.comThu, 25 Jun 2009 00:00:00 EDTjRSSGenerator by Henrique A. Viecilihttp://blogs.law.harvard.edu/tech/rsshttp://www.cookmedical.com/img/favicon.gifhttp://www.cookmedical.com8831http://www.cookmedical.com/newsDetail.do?id=4902Limerick, Ireland, June 29, 2009 – The Guardia Pro Protective Embryo Transfer Catheter is uniquely engineered to protect and guide embryos through cervical mucus and blood and to eliminate the need for cervical flushing or aspiration prior to transfer. David McCartyThu, 25 Jun 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4804Bloomington, Ind., June 2009 – Cook Medical has completed patient enrollment in its REFORM clinical trial, officials of Cook Medical reported today. The REFORM trial is designed to evaluate Cook's advanced Formula™ Balloon Expandable Stent for the treatment of renal artery stenosis, a narrowing of the renal artery that can result in hypertension, renal atrophy, and kidney failure if left untreated.David McCartyMon, 15 Jun 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4802Bloomington, Ind., June 11, 2009 – In a development aimed at enhancing safety for all patients undergoing endovascular repair of abdominal aortic aneurysms (EVAR) and open the clinical benefits of that minimally invasive procedure to millions of patients worldwide whose vascular anatomies are unsuited to the larger-diameter device in use today, Cook Medical has initiated enrollment in a U.S. clinical trial of its high-precision, next-generation Zenith® Low Profile AAA Endovascular Graft (Zenith AAA LP).David McCartyThu, 11 Jun 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4705Bloomington, Ind., June 2, 2009 – In a development aimed at improving patient outcomes, physicians treating thoracic aortic aneurysms (TAA) will now experience a new level of control while placing endografts during thoracic endovascular repair procedures. With the launch of Cook Medical's new Z-TRAK PLUS™ Introduction System, physicians are provided with improved maneuverability for controllable device orientation and deployment of the Zenith® TX2™ TAA Endovascular Stent Graft compared to earlier Cook delivery systems.David McCartyTue, 2 Jun 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4602Winston-Salem, N.C., May 26, 2009 – Physicians can now provide potentially safer and more accurate diagnostic procedures with the first and only high-definition endoscopic ultrasound (EUS) needle technology. Cook Medical, the only full-line supplier of endoscopic medical devices, has designed a complete line of high-definition EUS biopsy needles that are up to three-times brighter than others on the market. With the addition of the 19 and 25 gage EchoTip® Ultra with High Definition Fine Needle Aspiration (HDFNA™) needles, the EchoTip Ultra HDFNA represents the next level of precision in EUS, an essential diagnostic tool that yields more accurate images of the gastrointestinal (GI) tract than traditional ultrasound and provides minimally invasive access to areas that are traditionally difficult to reach.David McCartyTue, 26 May 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4505BLOOMINGTON, Ind. – Cory Lewis has joined Cook Pharmica, the global biopharmaceutical contract development and manufacturing division of Cook Medical, as director of business development. Marsha DawesFri, 15 May 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4504Bloomington, Ind., May 11, 2009 – With the launch of Cook Medical's new Spectrum Turbo-Ject PICC, for the first time, the clinical benefits of antibiotic-impregnated catheters—a critical component in eliminating 250,000 potentially fatal catheter-related bloodstream infections (CRBSIs) in the U.S. annually—are now available for peripherally inserted central venous catheters (PICCs) that can also be used for contrast-enhanced CT scans.Marsha DawesMon, 11 May 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4503Bloomington, Ind., May 5, 2009 – Through a strategic partnership between Cook Medical and Amerinet, 31,000 U.S. healthcare providers in 19 affiliate networks will gain access to Cook's diverse portfolio of advanced medical devices. Four new contracts, launched on April 1, will build on the companies' longstanding relationship to bring cost-effective, high-quality medical technology and devices to Amerinet's extensive base of providers.Dave McCartyTue, 5 May 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4402Bloomington, Ind., April 27, 2009 – The industry's first interactive, behind-the-scenes video takes viewers day-by-day through the techniques and procedures of in-vitro fertilization (IVF) through a new online destination from Cook Medical. CookARTLab.com is designed to improve laboratory and clinical performance in the field of assisted reproductive technology (A.R.T.). Gail McDanielSun, 3 May 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4502Chicago, Ill., April 28, 2009 – Cook Medical has agreed to become the exclusive sponsor of the American Urological Association's global exchange program. Details of exchange sponsorship were announced at a press conference during the AUA annual meeting in Chicago. Jerry French, senior vice president and strategic business leader for Cook Medical's urology division was joined by Dr. Joel Nelson, chair of the AUA/EAU Academic Fellowship Selection Committee and Dr. Ziya Kirkali, a past exchange participant from Turkey and upcoming chair of the AUA International Member Committee. Gail McDanielTue, 28 Apr 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4403Bloomington, Ind., April 27, 2009 – The results of a 16-month clinical study showing that the Cook Medical Resonance Metallic Ureteral Stent could remain in a patient for up to 12 months; generating a 43 percent cost savings in treating benign ureteral obstruction, will be presented by Dr. Thomas M. Turk, a member of the study's investigative team, during a press conference at the 2009 AUA Conference in Chicago on April 27. These results are compared to alternative polymer stent treatment methods which may require more frequent stent changes throughout the year. Gail McDanielMon, 27 Apr 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4303London, England, April 7, 2009 – Preliminary data presented today on two-year follow up show that 82 percent of patients who were treated with Cook Medical's Zilver® PTX™ drug-eluting peripheral stent (DES) were free from reintervention at two-year follow up. The Zilver PTX Registry study, involving 792 patients from across the world, is assessing the safety and efficacy of the Zilver PTX in treating PAD. The most recent results were reported at the 31st International Symposium: Charing Cross Controversies Challenges Consensus. Anna GueldenhauptTue, 7 Apr 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4302Bjaeverskov, Denmark, April 1, 2009 – Patients undergoing endovascular repair of thoracic aneurysms can now receive the clinical benefits of Cook Medical's new Zenith® TX2® TAA Endovascular Graft with Pro-Form™ for more controlled treatment of thoracic aortic aneurysms (TAAs). Cook's new TX2 Pro-Form endograft, which has received CE Mark approval, utilizes an improved delivery system that allows for carefully controlled deployment of the endograft to help ensure proximal conformity of the device to the aortic wall. This innovation offers patients unparalleled safety in endovascular TAA repair, even for procedures where endografts have to be positioned in what physicians consider to be uncommonly tight aortic arches, which are notoriously difficult to properly seal. Lucie SmithWed, 1 Apr 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4203Bloomington, Ind., March 23, 2009 – A five-year study confirms the long-term strength and durability of the Biodesign Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today.Marsha DawesMon, 23 Mar 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4204Bloomington, IN, March 19, 2009 – Cook Incorporated announced today that as part of its global effort to protect its extensive intellectual property portfolio, it will appeal promptly an initial ruling by the District Court of Düsseldorf, Germany denying the company's claim that Edwards Lifesciences is infringing Cook's German patent for transcatheter valve technology. David McCartyThu, 19 Mar 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4202Bloomington, Ind., March 10, 2009 – An 11-month clinical study led by Manish P. Patel, M.D., generated positive results on Cook Medical's Biodesign™ Vaginal Erosion Repair Graft for the treatment of vaginal mesh exposures, a common complication resulting from the use of synthetic mesh in pelvic floor repair, the procedure used to treat pelvic organ prolapse. The results, which confirmed the safety and efficacy of Biodesign, were presented at the 2009 Society for Urodynamics and Female Urology Winter Meeting in Las Vegas. Marsha DawesTue, 10 Mar 2009 00:00:00 EDThttp://www.cookmedical.com/newsDetail.do?id=4111Winston-Salem, NC, February 16, 2009 – Cook Medical's launch of Fusion® LoopTip™ sets a new standard for wire guide cannulation, the company announced today. LoopTip delivers potentially less traumatic access and navigation of the pancreatobiliary ductal system when diagnosing and treating conditions of the biliary and pancreatic ducts. These include gallstones, malignant and benign strictures, conditions gastroenterologists treat using endoscopic retrograde cholangiopancreatography (ERCP).David McCartyMon, 2 Mar 2009 00:00:00 ESThttp://www.cookmedical.com/newsDetail.do?id=4112London, February 19, 2009 – A first-of-its-kind operation has been performed in the UK using a newly developed medical device, the Zenith® Helical Branch Iliac Endovascular Graft from Cook Medical. Mr Ferdinand Serracino-Inglott, one of Europe's most experienced vascular surgeons, carried out the complex medical procedure on an 81 year old man at the Manchester Royal Infirmary using the Helical Branch Endograft from the Aortic Intervention business unit of Cook Medical, the global sales and technology leader in endovascular therapy products. The patient, Mr Dennis Ryan, was suffering from an aortic aneurysm (a weakening of the wall of the aorta), a condition that kills around 7,000 people in the UK every year.David McCartyThu, 19 Feb 2009 00:00:00 ESThttp://www.cookmedical.com/newsDetail.do?id=4108Bloomington, Ind., February 17, 2009 – As part of the company's new approach to making its Critical Care division products available to Japanese hospitals through direct sales, Cook Japan today introduced a new manager for that division. Mr. Kazuma Kusunose has strong leadership and sales skills that Cook hope will strength the Critical Care division and bring the benefits of Cook's advanced medical technologies to many more Japanese patients.Yuriko YamamotoTue, 17 Feb 2009 00:00:00 ESThttp://www.cookmedical.com/newsDetail.do?id=4107Bloomington, Ind., February 4, 2009 – Minocycline/rifampin-impregnated catheters are a critical component in modern health care practices designed to eliminate potentially fatal catheter-related bloodstream infections (CRBSIs) that affect 250,000 Americans a year, according to recently released clinical data from the Society of Critical Care Medicine's 38th Critical Care Congress. The first set of data reveal that an over-the-wire exchange of an infected central venous catheter (CVC) for a CVC impregnated with minocycline and rifampin, which are two antibiotic drugs that act together to dramatically reduce the risk of infections, can more quickly help eliminate an existing infection in cancer patients than currently recommended procedures. The second, a first ever head-to-head study that lasted 46 months, revealed that minocycline/rifampin-impregnated CVCs are nearly twice a effective at preventing CRBSIs than second generation CVCs coated with chlorahexidine/silver sulfadiazine solution.Marsha DawesWed, 4 Feb 2009 00:00:00 EST